These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11271205)

  • 1. Hepatitis C in liver transplant patients.
    Pons JA; Ramirez P; Miras M; Robles R; Bueno FS; Marin C; Alberca F; Torrella E; Parrilla P
    Transpl Int; 1994; 7 Suppl 1():S213-5. PubMed ID: 11271205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo hepatitis C in children after liver transplantation.
    McDiarmid SV; Conrad A; Ament ME; Vargas J; Martin MG; Goss JA; Busuttil RW
    Transplantation; 1998 Aug; 66(3):311-8. PubMed ID: 9721798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation.
    Thomas RM; Brems JJ; Guzman-Hartman G; Yong S; Cavaliere P; Van Thiel DH
    Liver Transpl; 2003 Sep; 9(9):905-15. PubMed ID: 12942451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.
    Gopal DV; Rabkin JM; Berk BS; Corless CL; Chou S; Olyaei A; Orloff SL; Rosen HR
    Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of hepatitis C virus after liver transplantation.
    Gugenheim J; Baldini E; Mazza D; Fabiani P; St Paul MC; Goubaux B; Ouzan D; Mouiel J
    Transpl Int; 1994; 7 Suppl 1():S224-6. PubMed ID: 11271209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation.
    Yedibela S; Schuppan D; Müller V; Schellerer V; Tannapfel A; Hohenberger W; Meyer T
    Liver Int; 2005 Aug; 25(4):717-22. PubMed ID: 15998420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of kidney transplant in chronic hepatitis C virus patients: effect of pretransplantation interferon-alpha2b monotherapy.
    González-Roncero F; Gentil MA; Valdivia MA; Algarra G; Pereira P; Toro J; Sayago M; Mateos J
    Transplant Proc; 2003 Aug; 35(5):1745-7. PubMed ID: 12962779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcome of hepatitis C virus infection after liver transplantation.
    Vargas V; Comas P; Castells L; Quer J; Esteban JI; Allende E; Esteban R; Guardia J; Margarit C
    Transpl Int; 1994; 7 Suppl 1():S216-20. PubMed ID: 11271206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    Arch Virol; 1997; 142(3):535-44. PubMed ID: 9349299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study.
    Mukherjee S; Gilroy RK; McCashland TM; Schafer DF
    Transplant Proc; 2003 Jun; 35(4):1478-9. PubMed ID: 12826198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
    Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
    Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection.
    Reiberger T; Rasoul-Rockenschaub S; Rieger A; Ferenci P; Gangl A; Peck-Radosavljevic M
    Eur J Clin Invest; 2008 Jun; 38(6):421-9. PubMed ID: 18489402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon Alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation.
    Wietzke P; Braun F; Ringe B; Ramadori G
    Transplant Proc; 2000 Nov; 32(7):2539-42. PubMed ID: 11120284
    [No Abstract]   [Full Text] [Related]  

  • 16. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated interferon alpha-2a and ribavirin combination therapy in HCV liver transplant recipients. Experience of 7 cases.
    Iacob S; Gheorghe L; Hrehoret D; Becheanu G; Herlea V; Popescu I
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):165-72. PubMed ID: 18568137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
    Gane EJ; Lo SK; Riordan SM; Portmann BC; Lau JY; Naoumov NV; Williams R
    Hepatology; 1998 May; 27(5):1403-7. PubMed ID: 9581698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus infection inhibits response of chronic hepatitis-C-virus-infected patients to interferon-based therapy.
    Bader el-Din NG; Abd el-Meguid M; Tabll AA; Anany MA; Esmat G; Zayed N; Helmy A; el-Zayady AR; Barakat A; el-Awady MK
    J Gastroenterol Hepatol; 2011 Jan; 26(1):55-62. PubMed ID: 21175794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 20-year case study of a kidney transplant recipient with chronic active hepatitis C: clinical course and successful treatment for late acute rejection induced by interferon therapy.
    Ichikawa Y; Kyo M; Hanafusa T; Kohro T; Kishikawa H; Fukunishi T; Nagano S; Shinji Y
    Transplantation; 1998 Jan; 65(1):134-8. PubMed ID: 9448159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.